<DOC>
	<DOCNO>NCT02427191</DOCNO>
	<brief_summary>Prospective , single-blinded , randomize control trial micronized dHACM injection compare saline placebo injection treatment plantar fasciitis</brief_summary>
	<brief_title>Micronized dHACM Injectable Treatment Plantar Fasciitis</brief_title>
	<detailed_description>Approximately 146 patient enrol study . Each patient receive 1 injection evaluate efficacy safety 12-month observation period additional evaluation 24 month . The study expect complete within 36 month , inclusive enrollment follow-up subject .</detailed_description>
	<mesh_term>Fasciitis</mesh_term>
	<mesh_term>Fasciitis , Plantar</mesh_term>
	<criteria>1 . Confirmed diagnosis plantar fasciitis ≥ 1 month ( 30 day ) ≤ 18 month investigator 2 . VAS Pain scale ≥ 45 mm randomization 3 . Plantar fasciitis conservative treatment ≥ 1 month ( 30 day ) , include follow modality : RICE Stretching exercise NSAIDs Orthotics 4 . Diagnostic XRay within 6 month enrollment show view calcaneus negative calcaneal fracture structural abnormality 5 . BMI ≤ 40 kg/m2 6 . Age ≥ 21 year &lt; 80 7 . Ability sign Informed Consent Release Medical Information Forms 1 . Prior surgery trauma affect site 2 . Subjects require bilateral plantar fasciitis treatment time enrollment 3 . Prior use low limb injection therapy , include corticosteroid PRP either limb within last 3 month 4 . Has diabetes either Type I Type II 5 . Systemic disorder associate enthesopathy ( disorder entheses , i.e . bone attachment ) Gout , Reiter 's syndrome , rheumatoid arthritis , etc . 6 . The presence comorbidities confuse exacerbate condition assess Xray include limited : Calcaneal stress fracture Nerve entrapment syndrome ( Baxter Nerve Syndrome ) Fat pad atrophy Acute traumatic rupture plantar fascia Calcaneal tumor Tarsal tunnel syndrome Significant bone deformity foot may interfere study 7 . Affected site exhibit clinical sign symptom infection 8 . Known allergy know sensitivity Aminoglycosides , Gentamicin sulfate Streptomycin sulfate 9 . Clinically significant abnormal laboratory test baseline , include CBC , PT/PTT/INR , liver function creatinine , determine investigator 10 . Patients nonambulatory 11 . History 14 day treatment immunosuppressant ( include systemic corticosteroid ) cytotoxic chemotherapy within 30 day prior enrollment , anticipated require medication course study 12 . Prior radiation site 13 . Use investigational drug ( ) therapeutic device ( ) within 3 month precede enrollment 14 . Immune disorder include Systemic Lupus Erythematosus ( SLE ) , Fibromyalgia , Acquired Immunodeficiency Syndrome ( AIDS ) Human Immunodeficiency Virus ( HIV ) 15 . History condition ( include drug alcohol abuse , medical psychiatric condition ) likely impair understand compliance study protocol , judgment investigator 16 . Pregnancy enrollment within last 6 month , woman breastfeed , woman childbearing potential planning become pregnant time study OR unwilling/unable use acceptable method contraception ( birth control pill , barrier , abstinence ) 17 . Workers ' compensation patient</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Chronic plantar fasciitis</keyword>
	<keyword>Heel pain</keyword>
</DOC>